Amila Patel, PharmD, BCOP, technical lead, Clinical Oncology, Flatiron Health, offers details on new clinical workflow features that will address some of the pain points clinicians have with the electronic medical record system.
Amila Patel, PharmD, BCOP, technical lead, Clinical Oncology, Flatiron Health, offers details on new clinical workflow features that will address some of the pain points clinicians have with the electronic medical record system.
Transcript
What are some new clinical workflow features that clinicians can look forward to in the coming year that will address some of the pain points they have?
Some of the things we’re working on in the coming year that we’re really excited about at Flatiron to introduce into OncoEMR are our visit notes and a redesign experience for how clinicians approach their documentation experience; our clinical inbox, which is how care team members collaborate to view and manage tasks within their inbox workflow; and the last thing we’re working on is a clinical decision support tools called Flatiron Assist that we’re also really excited about.
Does Flatiron take feedback from physicians to help make decisions on what new features should be inlcuded in clinical workflows?
Yes, definitely. We gather feedback from our customers on an ongoing basis. They have the availability to meet with our support teams., But in addition to that, we conduct user research before we start any developmental features to make sure we’re taking the input of our users as we’re developing features.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Strategies for Improving Patient Access to Dermatology Care
March 22nd 2025Elizabeth Jones, MD, FAAD, highlights the persistent issue of insurance companies favoring expensive, newer medications over equally effective generics in dermatology, emphasizing the time-consuming prior authorization process and advocating for patient partnerships and systemic improvements.
Read More
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More